153 related articles for article (PubMed ID: 29217453)
21. Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma.
Zhu Q; Pan QZ; Zhong AL; Hu H; Zhao JJ; Tang Y; Hu WM; Li M; Weng DS; Chen MY; Ma G; Xia JC
Int Immunopharmacol; 2020 Dec; 89(Pt A):107139. PubMed ID: 33191179
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
[TBL] [Abstract][Full Text] [Related]
23. Annexin A3 may play an important role in ochratoxin-induced malignant transformation of human gastric epithelium cells.
Wang J; Jia X; Meng X; Li Y; Wu W; Zhang X; Xu H; Cui J
Toxicol Lett; 2019 Oct; 313():150-158. PubMed ID: 31276768
[TBL] [Abstract][Full Text] [Related]
24. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis
Guo C; Li N; Dong C; Wang L; Li Z; Liu Q; Ma Q; Greenaway FT; Tian Y; Hao L; Liu S; Sun MZ
J Adv Res; 2021 May; 30():85-102. PubMed ID: 34026289
[TBL] [Abstract][Full Text] [Related]
25. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
26. Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ.
Ji ZM; Yang LL; Ni J; Xu SP; Yang C; Duan P; Lou LP; Ruan QR
Curr Med Sci; 2018 Jun; 38(3):461-466. PubMed ID: 30074213
[TBL] [Abstract][Full Text] [Related]
27. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
Li Z; Sun X; Liu X; Sun Z; Li J
Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
[No Abstract] [Full Text] [Related]
28. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
29. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
30. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
31. The role of annexin A3 playing in cancers.
Wu N; Liu S; Guo C; Hou Z; Sun MZ
Clin Transl Oncol; 2013 Feb; 15(2):106-10. PubMed ID: 23011854
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of annexin A3 promotes ionizing radiation-induced EGFR activation and nuclear translocation and confers radioresistance in nasopharyngeal carcinoma.
Yang L; Lu P; Yang X; Li K; Chen X; Zhou Y; Qu S
Exp Cell Res; 2022 Sep; 418(2):113292. PubMed ID: 35850266
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
34. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
[TBL] [Abstract][Full Text] [Related]
35. ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma.
Tong M; Fung TM; Luk ST; Ng KY; Lee TK; Lin CH; Yam JW; Chan KW; Ng F; Zheng BJ; Yuan YF; Xie D; Lo CM; Man K; Guan XY; Ma S
Stem Cell Reports; 2015 Jul; 5(1):45-59. PubMed ID: 26095609
[TBL] [Abstract][Full Text] [Related]
36. ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin.
Jin YF; Huang YT; Chen PF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3741-3748. PubMed ID: 32329851
[TBL] [Abstract][Full Text] [Related]
37. Annexin A3 is necessary for parallel artery-vein alignment in the mouse retina.
Huang K; Crist AM; Patel NR; Blanks A; Carter K; Cleaver O; Meadows SM
Dev Dyn; 2020 May; 249(5):666-678. PubMed ID: 32020697
[TBL] [Abstract][Full Text] [Related]
38. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
40. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]